{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AR/PKM2 axis", "Castration-resistant prostate cancer", "danshinone IIA derivative", "glycolysis", "pyruvic acid"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38447792", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": ["107139", "10.1016/j.jbc.2024.107139", "S0021-9258(24)01634-X"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "05"}], "Journal": {"ISSN": "1083-351X", "JournalIssue": {"Volume": "300", "Issue": "4", "PubDate": {"Year": "2024", "Month": "Apr"}}, "Title": "The Journal of biological chemistry", "ISOAbbreviation": "J Biol Chem"}, "ArticleTitle": "Tanshinone analog inhibits castration-resistant prostate cancer cell growth by inhibiting glycolysis in an AR-dependent manner.", "Pagination": {"StartPage": "107139", "MedlinePgn": "107139"}, "Abstract": {"AbstractText": ["Androgen receptor (AR) is one of the key targets for the treatment of castration-resistant prostate cancer (CRPC). Current endocrine therapy can greatly improve patients with CRPC. However, with the change of pathogenic mechanism, acquired resistance often leads to the failure of treatment. Studies have shown that tanshinone IIA (TS-IIA) and its derivatives have significant antitumor activity, and have certain AR-targeting effects, but the mechanism is unknown. In this study, the TS-IIA analog TB3 was found to significantly inhibit the growth of CRPC in\u00a0vitro and in\u00a0vivo. Molecular docking, cellular thermal shift assay, and cycloheximide experiments confirmed that AR was the target of TB3 and promoted the degradation of AR. Furthermore, TB3 can significantly inhibit glycolysis metabolism by targeting the AR/PKM2 axis. The addition of pyruvic acid could significantly alleviate the inhibitory effect of TB3 on CRPC cells. Besides, the knockdown of AR or PKM2 also could reverse the effect of TB3 on CRPC cells. Taken together, our study suggests that TS-IIA derivative TB3 inhibits glycolysis to prevent the CRPC process by targeting the AR/PKM2 axis."], "CopyrightInformation": "Copyright \u00a9 2024 The Authors. Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang, PR China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou University, Guiyang, PR China; Department of Pharmacy, Guizhou Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guiyang, PR China."}], "LastName": "Li", "ForeName": "Shengyou", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang, PR China."}], "LastName": "Cheng", "ForeName": "Sha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China."}], "LastName": "Ahmad", "ForeName": "Mashaal", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang, PR China."}], "LastName": "Chen", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang, PR China."}], "LastName": "Wan", "ForeName": "Xinwei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang, PR China."}], "LastName": "Wei", "ForeName": "Shinan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; School of Pharmaceutical Sciences, Guizhou University, Guiyang, PR China. Electronic address: wdpan@163.com."}], "LastName": "Pan", "ForeName": "Weidong", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, PR China; Institute of Pharmacology and Bioactivity, Natural Products Research Center of Guizhou Province, Guiyang, PR China. Electronic address: luoheng71050@aliyun.com."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Biol Chem", "NlmUniqueID": "2985121R", "ISSNLinking": "0021-9258"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Abietanes"}, {"RegistryNumber": "0", "NameOfSubstance": "AR protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Carrier Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Androgen"}, {"RegistryNumber": "03UUH3J385", "NameOfSubstance": "tanshinone"}, {"RegistryNumber": "0", "NameOfSubstance": "Thyroid Hormone-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Thyroid Hormones"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Abietanes"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Carrier Proteins"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Glycolysis"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["metabolism", "pathology", "drug therapy"], "DescriptorName": "Prostatic Neoplasms, Castration-Resistant"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Receptors, Androgen"}, {"QualifierName": [], "DescriptorName": "Thyroid Hormone-Binding Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Thyroid Hormones"}], "CoiStatement": "Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nevedomskaya E., Baumgart S.J., Haendler B. Recent advances in prostate cancer treatment and drug discovery. Int. J. Mol. Sci. 2018;19:1359.", "ArticleIdList": ["PMC5983695", "29734647"]}, {"Citation": "Yap T.A., Smith A.D., Ferraldeschi R., Al-Lazikani B., Workman P., de Bono J.S. Drug discovery in advanced prostate cancer: translating biology into therapy. Nat. Rev. Drug Discov. 2016;15:699\u2013718.", "ArticleIdList": ["27444228"]}, {"Citation": "Chen W., Zheng R., Baade P.D., Zhang S., Zeng H., Bray F., et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 2016;66:115\u2013132.", "ArticleIdList": ["26808342"]}, {"Citation": "Watson P.A., Arora V.K., Sawyers C.L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer. 2015;15:701\u2013711.", "ArticleIdList": ["PMC4771416", "26563462"]}, {"Citation": "Wang K., Ruan H., Xu T., Liu L., Liu D., Yang H., et al. Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer. OncoTargets Ther. 2018;11:3167\u20133178.", "ArticleIdList": ["PMC5983013", "29881290"]}, {"Citation": "Galletti G., Leach B.I., Lam L., Tagawa S.T. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer. Cancer Treat. Rev. 2017;57:16\u201327.", "ArticleIdList": ["28527407"]}, {"Citation": "Shorning B.Y., Dass M.S., Smalley M.J., Pearson H.B. The PI3K-AKT-mTOR pathway and prostate cancer: at the Crossroads of AR, MAPK, and WNT signaling. Int. J. Mol. Sci. 2020;21:4507.", "ArticleIdList": ["PMC7350257", "32630372"]}, {"Citation": "Wu C.Y., Yang Y.H., Lin Y.Y., Kuan F.C., Lin Y.S., Lin W.Y., et al. Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway. Oncotarget. 2017;8:40246\u201340263.", "ArticleIdList": ["PMC5522253", "28157698"]}, {"Citation": "Jiang Z., Gao W., Huang L. Tanshinones, critical pharmacological components in Salvia miltiorrhiza. Front. Pharmacol. 2019;10:202.", "ArticleIdList": ["PMC6426754", "30923500"]}, {"Citation": "Hu X., Jiao F., Zhang L., Jiang Y. Dihydrotanshinone inhibits Hepatocellular carcinoma by suppressing the JAK2/STAT3 pathway. Front. Pharmacol. 2021;12", "ArticleIdList": ["PMC8117156", "33995073"]}, {"Citation": "Lai Z., He J., Zhou C., Zhao H., Cui S. Tanshinones: an update in the medicinal chemistry in recent 5 Years. Curr. Med. Chem. 2021;28:2807\u20132827.", "ArticleIdList": ["32436817"]}, {"Citation": "Li W., Huang T., Xu S., Che B., Yu Y., Zhang W., et al. Molecular mechanism of tanshinone against prostate cancer. Molecules. 2022;27:5594.", "ArticleIdList": ["PMC9457553", "36080361"]}, {"Citation": "Xu D., Hu H., Guan J., Da J., Xie Y., Liu Y., et al. Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer. Chem. Biol. Drug Des. 2019;94:1656\u20131663.", "ArticleIdList": ["31108007"]}, {"Citation": "Xu D., Lin T.H., Zhang C., Tsai Y.C., Li S., Zhang J., et al. The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells. Prostate. 2012;72:803\u2013816.", "ArticleIdList": ["21932429"]}, {"Citation": "Li S.Y., Sun Z.K., Zeng X.Y., Zhang Y., Wang M.L., Hu S.C., et al. Potent cytotoxicity of novel L-Shaped Ortho-Quinone analogs through inducing apoptosis. Molecules. 2019;24:4138.", "ArticleIdList": ["PMC6891391", "31731682"]}, {"Citation": "Zhang X.B., Chen X.Y., Sun P., Su X.M., Zeng H.Q., Zeng Y.M., et al. Sodium tanshinone IIA Sulfonate attenuates tumor oxidative stress and promotes apoptosis in an Intermittent Hypoxia mouse model. Technol. Cancer Res. Treat. 2020;19", "ArticleIdList": ["PMC7249596", "32431212"]}, {"Citation": "Sosa V., Molin\u00e9 T., Somoza R., Paciucci R., Kondoh H., LLeonart M.E. Oxidative stress and cancer: an overview. Ageing Res. Rev. 2013;12:376\u2013390.", "ArticleIdList": ["23123177"]}, {"Citation": "Li Z., Zhang Y., Zhang K., Wu Z., Feng N. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Artif. Cells Nanomed. Biotechnol. 2018;46:578\u2013587.", "ArticleIdList": ["29374971"]}, {"Citation": "Seashore-Ludlow B., Axelsson H., Lundb\u00e4ck T. Perspective on CETSA Literature: toward more Quantitative data Interpretation. SLAS Discov. 2020;25:118\u2013126.", "ArticleIdList": ["31665966"]}, {"Citation": "Sui H., Zhao J., Zhou L., Wen H., Deng W., Li C., et al. Tanshinone IIA inhibits \u03b2-catenin/VEGF-mediated angiogenesis by targeting TGF-\u03b21 in normoxic and HIF-1\u03b1 in hypoxic microenvironments in human colorectal cancer. Cancer Lett. 2017;403:86\u201397.", "ArticleIdList": ["28602978"]}, {"Citation": "Li X., Jia Q., Zhou Y., Jiang X., Song L., Wu Y., et al. Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis. Exp. Hematol. Oncol. 2022;11:2.", "ArticleIdList": ["PMC8781032", "35057866"]}, {"Citation": "Won S.H., Lee H.J., Jeong S.J., L\u00fc J., Kim S.H. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells. Phytother. Res. 2012;26:669\u2013674.", "ArticleIdList": ["21997969"]}, {"Citation": "Liu W., Zhou J., Geng G., Shi Q., Sauriol F., Wu J.H. Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A. J.\u00a0Med. Chem. 2012;55:971\u2013975.", "ArticleIdList": ["22175694"]}, {"Citation": "Zhang Y., Won S.H., Jiang C., Lee H.J., Jeong S.J., Lee E.O., et al. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling. Pharm. Res. 2012;29:1595\u20131608.", "ArticleIdList": ["22281759"]}, {"Citation": "Zhang W., Liu C., Li J., Lu Y., Li H., Zhuang J., et al. Tanshinone IIA: new perspective on the anti-tumor mechanism of A Traditional Natural medicine. Am. J. Chin. Med. 2022;50:209\u2013239.", "ArticleIdList": ["34983327"]}, {"Citation": "Li M., Gao F., Zhao Q., Zuo H., Liu W., Li W. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis. Cell Death Dis. 2020;11:381.", "ArticleIdList": ["PMC7235009", "32424132"]}, {"Citation": "Liu Z., Zhu W., Kong X., Chen X., Sun X., Zhang W., et al. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer. Oncol. Rep. 2019;42:1893\u20131903.", "ArticleIdList": ["PMC6775814", "31485631"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "21"}, {"Year": "2024", "Month": "2", "Day": "5"}, {"Year": "2024", "Month": "2", "Day": "14"}, {"Year": "2024", "Month": "4", "Day": "28", "Hour": "7", "Minute": "24"}, {"Year": "2024", "Month": "3", "Day": "7", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "3", "Day": "6", "Hour": "19", "Minute": "17"}, {"Year": "2024", "Month": "3", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38447792", "PMC11002303", "10.1016/j.jbc.2024.107139", "S0021-9258(24)01634-X"]}}]}